Natural stem cell mobilizers for treating Parkinson's disease
Open-labeled Pilot Study on the Efficacy of a New Food Supplement Composed of Natural Stem Cell Mobilizers for the Improvement of Motor Performance and Quality of Life in Parkinsonian Patients
This study is testing a food supplement called StemRegen to see if it can help people with Parkinson's disease by boosting their body's natural stem cell circulation to repair damaged brain cells.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 21 Years to 90 Years |
| Sex | All |
| Sponsor | Sociedad Española de Medicina Regenerativa y Terapia Celular Academic / other |
| Locations | 1 site (Madrid) |
| Trial ID | NCT05699694 on ClinicalTrials.gov |
What this trial studies
This clinical study investigates the efficacy of a food supplement designed to increase the circulation of stem cells in the peripheral blood as a potential treatment for Parkinson's disease. Participants will take the supplement, StemRegen, in capsule form, with the aim of enhancing the body's natural repair mechanisms for dopaminergic neurons. The study focuses on adults diagnosed with Parkinson's disease for at least five years who have stabilized their symptoms. The approach is based on the premise that mobilizing stem cells may help repair tissue affected by the disease.
Who should consider this trial
Good fit: Ideal candidates are adults over 21 years old, diagnosed with Parkinson's disease for five years or more, and stabilized on their current treatment.
Not a fit: Patients with gastrointestinal surgeries affecting nutrient absorption or those with uncontrolled evolving diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could improve the management of Parkinson's disease symptoms and enhance the quality of life for patients.
How similar studies have performed: While the approach of using natural stem cell mobilizers is relatively novel, there have been some studies exploring similar concepts in regenerative medicine.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults from both genders * Diagnosed by neurologist or qualified health care practitioner with PD for 5 years or more * Stabilized symptomatic treatment for PD for more than 3 months * Age: over 21 years old * Volunteers able to understand the nature of the study and to sign a written consent form Exclusion Criteria: * Gastro-intestinal surgery that may modify or decrease the intestinal absorption of nutrient and experimental product * Serious traumatism in the last 3 months * Heavy surgery operation in the last 3 months * Non-controlled evolutive disease * Drug or medication abuse in the last 2 years * History of non-compliance in previous studies * Regular consumption of similar ingredients or food supplements compared to experimental product in the past 3 months * Any medical problem or trouble identified by the investigator that could alter the capacity of the volunteer to end the study * Any drug medication that could mask, decrease or interfere experimental product efficacy * Surgery operation planned during the year * Breastfeeding, pregnant women * Known allergies to one of the ingredients entering in the composition of the experimental product * Severe liver and renal failure * Actual participation to another clinical trial
Where this trial is running
Madrid
- Clinica Castello 68 — Madrid, Spain (Recruiting)
Study contacts
- Principal investigator: Miguel G Garber, MD — Healthy Longevity Clinic
- Study coordinator: Miguel G Garber, MD
- Email: mggarber@gmail.com
- Phone: 34 628766753
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.